Long-term survival with tumor regression in androgen-induced liver tumors
Open Access
- 1 December 1985
- Vol. 56 (11) , 2622-2626
- https://doi.org/10.1002/1097-0142(19851201)56:11<2622::aid-cncr2820561115>3.0.co;2-0
Abstract
Two patients with androgen‐induced liver tumors, one of whom had been partially treated by a liver resection, are reported. Hepatocellular carcinoma was diagnosed on histologic grounds. The patients had been receiving androgen therapy for primary diagnoses of either hypopituitarism or paroxysmal nocturnal hemoglobinuria. After androgen withdrawal, both are alive and well with no evidence of residual tumor 10 and 14 years after diagnosis, respectively.This publication has 21 references indexed in Scilit:
- The use and misuse of androgensMetabolism, 1980
- ANDROGEN-INDUCED HEPATOMAThe Lancet, 1975
- Hepatoma associated with androgen therapy for aplastic anemiaThe Journal of Pediatrics, 1974
- ANDROGENIC-ANABOLIC STEROID THERAPY AND HEPATOCELLULAR CARCINOMAThe Lancet, 1973
- ANDROGENS AND HEPATOCELLULAR CARCINOMAThe Lancet, 1973
- ANDROGENIC STEROIDS AND HEPATOCELLULAR CARCINOMAThe Lancet, 1973
- ASSOCIATION OF ANDROGENIC-ANABOLIC STEROID THERAPY WITH DEVELOPMENT OF HEPATOCELLULAR CARCINOMAPublished by Elsevier ,1972
- Hepatoma and Peliosis Hepatis Developing in a Patient with Fanconi's AnemiaNew England Journal of Medicine, 1971
- Fanconi's anemia and hepatic cirrhosisThe American Journal of Medicine, 1965
- Clinical syndromes associated with gonadal failure in menThe American Journal of Medicine, 1947